Last updated 4 months ago
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
100 patients around the world
Available in United States, Mexico, Brazil
Incyte Corporation
9Research sites
100Patients around the world
This study is for people with
Solid tumors
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Oncocentro - Belo Horizonte
Oncocentro - Belo Horizonte
UPCO Unidade de Pesquisa Clinica em Oncologia
UPCO Unidade de Pesquisa Clinica em Oncologia
Hospital Nossa Senhora da Conceição
Hospital Nossa Senhora da Conceição
Instituto de Oncologia Saint Gallen
Instituto de Oncologia Saint Gallen
Preparaciones Oncológicas S.C. - Mexico
Preparaciones Oncológicas S.C. - Mexico
Cryptex Investigación Clínica
Cryptex Investigación Clínica
Clinical Medical Research S.C.
Clinical Medical Research S.C.
Centro Potosino de Investigación Médica
Centro Potosino de Investigación Médica
Centro Médico Zambrano Hellion
Centro Médico Zambrano Hellion
SponsorIncyte Corporation
Conditions
Solid tumors
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05909995
